AMSub 7 Parti F S322 AWS
. . . PARTICIPATING FACULTY . . . Asthma Management Alternatives for the New Millennium Proceedings in this Special Report supplement to The American Journal of Managed Care are based on presentations and roundtable discussions that took place in Scottsdale, Arizona, on December 1, 1999.
SYMPOSIUM PANEL AND FACULTY Chairs Alkis G. Togias, MD Associate Professor of Medicine Johns Hopkins University School of Medicine Divisions of Clinical Immunology and Respiratory and Critical Care Medicine at the Johns Hopkins Asthma and Allergy Center Baltimore, Maryland
Arthur Turk, MD Associate Clinical Professor of Medicine University of California, Irvine Tustin, California
Faculty Stuart A. Berney, PhD Corporate Pharmacy Director Access Health Systems, Inc Nashville, Tennessee Steven Eisenberg, MD Medical Director Blue Cross Blue Shield of Minnesota Eagan, Minnesota Matthew Emons, MD, MBA Medical Director Humana Louisville, Kentucky Traci Hardin, MPH Health Management Coordinator Companion HealthCare Columbia, South Carolina Diana Hopper, RN, BSN Quality Operations Project Manager SELECTCARE, INC Troy, Michigan Ross M. Miller, MD, MPH Medical Director, Quality Management CIGNA HealthCare Western Region Operations Glendale, California
S322
Robert A. Nathan, MD Associate Clinical Professor of Medicine University of Colorado Health Sciences Center Denver, Colorado David A. Stempel, MD Allergist Virginia Mason Clinic Seattle, Washington Stuart W. Stoloff, MD Clinical Associate Professor of Family and Community Medicine University of Nevada Carson City, Nevada MaryAnn Stump, RN Vice President, Strategic Innovation Blue Cross Blue Shield of Minnesota Eagan, Minnesota Joseph Tung, PharmD Director of Clinical Programs Blue Cross Blue Shield of Texas Dallas, Texas
THE AMERICAN JOURNAL OF MANAGED CARE
APRIL 2000
DISCLOSURE STATEMENT It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. These participants have declared the following affiliations with corporate organizations. ■
Robert A. Nathan, MD Grant/Research Support From: Abbott AstraZeneca Bayer Berlex Boehringer Ingelheim Bristol-Myers Squibb Ciba-Geigy Dura Forest GlaxoWellcome Hoechst Marion Roussel Immunex Janssen Parke-Davis Pfizer 3M Pharmaceuticals Proctor & Gamble Rhone-Poulenc Rorer Roberts Sandoz Sanofi Schering/Key Sepracor SmithKline Beecham Sterling TAP Pharmaceuticals Wallace Wyeth Ayerst Consultant/Scientific Advisor To: AstraZeneca Genentech GlaxoWellcome Hoechst Marion Roussel Immunex 3M Pharmaceuticals Merck Rhone-Poulenc Rorer Schering/Key
VOL. 6, NO. 7, SUP.
Lecture Support From: AstraZeneca GlaxoWellcome Hoechst Marion Roussel Merck Pfizer Rhone-Poulenc Rorer Schering/Key ■
David A. Stempel, MD Consultant To/Lecture Support From: Glaxo Wellcome Lecture Support From: Merck
■
Stuart W. Stoloff, MD Adviory Board Member To: AstraZeneca Consultant To: GlaxoWellcome Lecture Support From: Schering/Key Aventis
■
Alkis G. Togias, MD Grant/Research Support From: GlaxoWellcome Schering-Plough Novartis Genentech Lecture Support From: GlaxoWellcome AstraZeneca Pfizer Advisor To: AstraZeneca Schering-Plough Novartis Genentech Merck
THE AMERICAN JOURNAL OF MANAGED CARE
S323
DISCLOSURE STATEMENT ■
Mary Ann Stump, RN Advisory Board Member To: Robert Wood Johnson
■
Arthur Turk, MD Lecture Support From/Advisor To: AstraZeneca Aventis GlaxoWellcome Merck Schering
The participants listed below declare no financial arrangements or affiliations with any corporate organizations. ■ ■ ■
Stuart A. Berney, PhD Steven Eisenberg, MD Matthew Emons, MD, MBA
■ ■ ■ ■
Traci Hardin, MPH Diana Hopper, NN, BSN Ross M. Miller, MD, MPH Joseph Tung, PharmD
Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.
S324
THE AMERICAN JOURNAL OF MANAGED CARE
APRIL 2000
SYMPOSIUM PANEL AND FACULTY Chairs Alkis G. Togias, MD Associate Professor of Medicine Johns Hopkins University School of Medicine Divisions of Clinical Immunology and Respiratory and Critical Care Medicine at the Johns Hopkins Asthma and Allergy Center Baltimore, Maryland
Arthur Turk, MD Associate Clinical Professor of Medicine University of California, Irvine Tustin, California
Faculty Stuart A. Berney, PhD Corporate Pharmacy Director Access Health Systems, Inc Nashville, Tennessee Steven Eisenberg, MD Medical Director Blue Cross Blue Shield of Minnesota Eagan, Minnesota Matthew Emons, MD, MBA Medical Director Humana Louisville, Kentucky Traci Hardin, MPH Health Management Coordinator Companion HealthCare Columbia, South Carolina Diana Hopper, RN, BSN Quality Operations Project Manager SELECTCARE, INC Troy, Michigan Ross M. Miller, MD, MPH Medical Director, Quality Management CIGNA HealthCare Western Region Operations Glendale, California
S322
Robert A. Nathan, MD Associate Clinical Professor of Medicine University of Colorado Health Sciences Center Denver, Colorado David A. Stempel, MD Allergist Virginia Mason Clinic Seattle, Washington Stuart W. Stoloff, MD Clinical Associate Professor of Family and Community Medicine University of Nevada Carson City, Nevada MaryAnn Stump, RN Vice President, Strategic Innovation Blue Cross Blue Shield of Minnesota Eagan, Minnesota Joseph Tung, PharmD Director of Clinical Programs Blue Cross Blue Shield of Texas Dallas, Texas
THE AMERICAN JOURNAL OF MANAGED CARE
APRIL 2000
DISCLOSURE STATEMENT It is the policy of The American Journal of Managed Care to have all faculty who participate in programs sponsored by corporate organizations disclose any real or apparent conflicts of interest. These participants have declared the following affiliations with corporate organizations. ■
Robert A. Nathan, MD Grant/Research Support From: Abbott AstraZeneca Bayer Berlex Boehringer Ingelheim Bristol-Myers Squibb Ciba-Geigy Dura Forest GlaxoWellcome Hoechst Marion Roussel Immunex Janssen Parke-Davis Pfizer 3M Pharmaceuticals Proctor & Gamble Rhone-Poulenc Rorer Roberts Sandoz Sanofi Schering/Key Sepracor SmithKline Beecham Sterling TAP Pharmaceuticals Wallace Wyeth Ayerst Consultant/Scientific Advisor To: AstraZeneca Genentech GlaxoWellcome Hoechst Marion Roussel Immunex 3M Pharmaceuticals Merck Rhone-Poulenc Rorer Schering/Key
VOL. 6, NO. 7, SUP.
Lecture Support From: AstraZeneca GlaxoWellcome Hoechst Marion Roussel Merck Pfizer Rhone-Poulenc Rorer Schering/Key ■
David A. Stempel, MD Consultant To/Lecture Support From: Glaxo Wellcome Lecture Support From: Merck
■
Stuart W. Stoloff, MD Adviory Board Member To: AstraZeneca Consultant To: GlaxoWellcome Lecture Support From: Schering/Key Aventis
■
Alkis G. Togias, MD Grant/Research Support From: GlaxoWellcome Schering-Plough Novartis Genentech Lecture Support From: GlaxoWellcome AstraZeneca Pfizer Advisor To: AstraZeneca Schering-Plough Novartis Genentech Merck
THE AMERICAN JOURNAL OF MANAGED CARE
S323
DISCLOSURE STATEMENT ■
Mary Ann Stump, RN Advisory Board Member To: Robert Wood Johnson
■
Arthur Turk, MD Lecture Support From/Advisor To: AstraZeneca Aventis GlaxoWellcome Merck Schering
The participants listed below declare no financial arrangements or affiliations with any corporate organizations. ■ ■ ■
Stuart A. Berney, PhD Steven Eisenberg, MD Matthew Emons, MD, MBA
■ ■ ■ ■
Traci Hardin, MPH Diana Hopper, NN, BSN Ross M. Miller, MD, MPH Joseph Tung, PharmD
Signed disclosures are on file at the offices of The American Journal of Managed Care, Jamesburg, New Jersey.
S324
THE AMERICAN JOURNAL OF MANAGED CARE
APRIL 2000
